PE34397A1 - INHIBITION OF THE PHOTODESCOMPOSITION OF 2-OXYDOLES 3-SUBSTITUTED - Google Patents
INHIBITION OF THE PHOTODESCOMPOSITION OF 2-OXYDOLES 3-SUBSTITUTEDInfo
- Publication number
- PE34397A1 PE34397A1 PE1996000275A PE00027596A PE34397A1 PE 34397 A1 PE34397 A1 PE 34397A1 PE 1996000275 A PE1996000275 A PE 1996000275A PE 00027596 A PE00027596 A PE 00027596A PE 34397 A1 PE34397 A1 PE 34397A1
- Authority
- PE
- Peru
- Prior art keywords
- substituted
- photodescomposition
- oxydoles
- inhibition
- red
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polymerisation Methods In General (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
CARACTERIZADO POR LA INTRODUCCION DE UN MEDIO FOTOABSORBENTE (CAPAZ DE ABSORBER LAS LONGITUDES DE ONDA DE LA LUZ, MENORES DE 600 nm.), QUE COMPRENDE UN RECUBRIMIENTO DEL COMPRIMIDO O CAPSULA QUE CONTIENE LA 2-OXINDOL 1-CARBOXAMIDA 3-SUSTITUIDA DE FORMULA (I), DONDE: X ES H, Cl O F; Y ES H O Cl; R ES BENCILO O TIENILO OPCIONALMENTE SUSTITUIDO CON Cl O F. ESTE RECUBRIMIENTO COMPRENDE SUFICIENTE COLORANTE Y LACA AMARILLO N�6, ROJO N�3 Y ROJO N�40 O UNICAMENTE AMARILLO N�6, COMO PARA REDUCIR SIGNIFICATIVAMENTE LA FORMACION DE PRODUCTOS DE DEGRADACION INDUCIDOS POR LA LUZCHARACTERIZED BY THE INTRODUCTION OF A PHOTOABSORBENT MEDIA (ABLE TO ABSORB LIGHT WAVE LENGTHS, LESS THAN 600 nm.), WHICH INCLUDES A COATING OF THE TABLET OR 2-OXINDOL 3-SUBSTITUTED FORM ( I), WHERE: X IS H, Cl OF; Y IS H O Cl; R IS BENCIL OR TENYLL OPTIONALLY REPLACED WITH Cl O F. THIS COATING INCLUDES SUFFICIENT DYE AND LACQUER YELLOW N�6, RED N�3 AND RED N�40 OR ONLY YELLOW N�6, AS TO SIGNIFICANTLY REDUCE THE FORMATION OF DEGRADING PRODUCTS INDUCED BY LIGHT
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB1995/000287 WO1996033701A1 (en) | 1995-04-24 | 1995-04-24 | Inhibiting photodecomposition of 3-substituted-2-oxindoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE34397A1 true PE34397A1 (en) | 1997-09-29 |
Family
ID=36997502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1996000275A PE34397A1 (en) | 1995-04-24 | 1996-04-22 | INHIBITION OF THE PHOTODESCOMPOSITION OF 2-OXYDOLES 3-SUBSTITUTED |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0827399A1 (en) |
| JP (1) | JPH10506635A (en) |
| KR (1) | KR100189585B1 (en) |
| CN (1) | CN1053667C (en) |
| AP (1) | AP607A (en) |
| AR (1) | AR002728A1 (en) |
| AU (1) | AU692378B2 (en) |
| BG (1) | BG100531A (en) |
| BR (1) | BR9602024A (en) |
| CO (1) | CO4700418A1 (en) |
| FI (1) | FI973988L (en) |
| HR (1) | HRP960194A2 (en) |
| HU (1) | HU216544B (en) |
| IL (1) | IL117969A0 (en) |
| IS (1) | IS4339A (en) |
| MA (1) | MA23848A1 (en) |
| NO (1) | NO961622L (en) |
| NZ (1) | NZ286432A (en) |
| OA (1) | OA10286A (en) |
| PE (1) | PE34397A1 (en) |
| RO (1) | RO113305B1 (en) |
| RU (1) | RU2109510C1 (en) |
| SG (1) | SG64924A1 (en) |
| SI (1) | SI9600133A (en) |
| SK (1) | SK51296A3 (en) |
| TR (1) | TR199600300A2 (en) |
| UA (1) | UA42739C2 (en) |
| WO (1) | WO1996033701A1 (en) |
| YU (1) | YU25096A (en) |
| ZA (1) | ZA963210B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017445026B2 (en) | 2017-12-29 | 2024-09-05 | Kraft Foods Group Brands Llc | Improved oxidative stability of oil-in-water emulsions using natural stabilizers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3136282A1 (en) * | 1981-09-12 | 1983-03-24 | Hoechst Ag | "METHOD FOR STABILIZING PHOTO-UNSTABLE MEDICINAL PRODUCTS AND STABILIZED MEDICAL PREPARATIONS" |
| HUT59592A (en) * | 1990-07-20 | 1992-06-29 | Egyt Gyogyszervegyeszeti Gyar | Process for the preparation of solid medical products |
| TW438798B (en) * | 1992-10-07 | 2001-06-07 | Pfizer | 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions |
-
1995
- 1995-04-24 EP EP95914494A patent/EP0827399A1/en not_active Ceased
- 1995-04-24 RU RU96108120A patent/RU2109510C1/en active
- 1995-04-24 JP JP8532298A patent/JPH10506635A/en active Pending
- 1995-04-24 SK SK512-96A patent/SK51296A3/en unknown
- 1995-04-24 FI FI973988A patent/FI973988L/en unknown
- 1995-04-24 WO PCT/IB1995/000287 patent/WO1996033701A1/en not_active Ceased
- 1995-04-24 UA UA96041574A patent/UA42739C2/en unknown
-
1996
- 1996-03-07 AP APAP/P/1996/000787A patent/AP607A/en active
- 1996-03-28 AR ARP960101956A patent/AR002728A1/en unknown
- 1996-04-10 TR TR96/00300A patent/TR199600300A2/en unknown
- 1996-04-18 IL IL11796996A patent/IL117969A0/en unknown
- 1996-04-19 IS IS4339A patent/IS4339A/en unknown
- 1996-04-19 SG SG1996009306A patent/SG64924A1/en unknown
- 1996-04-22 CO CO96019210A patent/CO4700418A1/en unknown
- 1996-04-22 CN CN96105084A patent/CN1053667C/en not_active Expired - Fee Related
- 1996-04-22 RO RO96-00843A patent/RO113305B1/en unknown
- 1996-04-22 PE PE1996000275A patent/PE34397A1/en not_active Application Discontinuation
- 1996-04-23 AU AU50851/96A patent/AU692378B2/en not_active Ceased
- 1996-04-23 HR HRPCT/IB95/00287A patent/HRP960194A2/en not_active Application Discontinuation
- 1996-04-23 NZ NZ286432A patent/NZ286432A/en unknown
- 1996-04-23 BG BG100531A patent/BG100531A/en unknown
- 1996-04-23 HU HU9601057A patent/HU216544B/en not_active IP Right Cessation
- 1996-04-23 YU YU25096A patent/YU25096A/en unknown
- 1996-04-23 NO NO961622A patent/NO961622L/en unknown
- 1996-04-23 MA MA24209A patent/MA23848A1/en unknown
- 1996-04-23 ZA ZA9603210A patent/ZA963210B/en unknown
- 1996-04-23 KR KR1019960012356A patent/KR100189585B1/en not_active Expired - Fee Related
- 1996-04-24 OA OA60821A patent/OA10286A/en unknown
- 1996-04-24 SI SI9600133A patent/SI9600133A/en not_active IP Right Cessation
- 1996-04-24 BR BR9602024A patent/BR9602024A/en active Search and Examination
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2164182T3 (en) | BENZOCICLOPENTANOXAZOLIDINONES THAT CONTAIN HETEROATOMOS WITH ANTIBACTERIAL ACTIVITY. | |
| MX9306023A (en) | CHINOLONCARBOXYLIC ACIDS AND PROCEDURE FOR THEIR OBTAINING. | |
| ES2080134T3 (en) | INDOLINO-SPIRO-OXAZINE-TYPE PHOTO-CHROME COMPOUNDS, THEIR PREPARATION PROCEDURE, COMPOSITIONS AND PHOTO-CHROME ARTICLES CONTAINING SUCH COMPOUNDS. | |
| TW269682B (en) | ||
| ES2138622T3 (en) | DERIVATIVES OF MERCAPTOACETILAMIDO PIRIDAZO (1,2-A) (1,2) DIAZEPINA USED AS ENCEPHALINASE AND ECA INHIBITORS. | |
| MX9503529A (en) | Glycinamide derivatives, process for their preparation and medicaments containing them. | |
| CO4950529A1 (en) | DIHYDROPYRIMIDINES AND PRODUCTS CONTAINING THEM | |
| AR004087A1 (en) | DERIVATIVE OF PHENYLACETIC ACID, PROCEDURES AND INTERMEDIATE PRODUCTS FOR THEIR OBTAINING AND THE COMPOSITIONS CONTAINING THEM | |
| ES2093494T3 (en) | PURIFIED HEPARIN FRACTIONS, OBTAINING PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| AR038427A2 (en) | COMPOUNDS 15-RENT-14-HYDROXYL OF MARCFORTINA AND PARAHERCUAMIDA | |
| MX9302461A (en) | BENZO-AND PIRIDOPIRIDONES SUBSTITUTED BY SULFONILBENCILO, PROCEDURE FOR THEIR OBTAINING AND MEDICINES THAT CONTAIN THEM. | |
| ES2194023T3 (en) | PROCEDURE TO PREPARE BENZOPIRAN COMPOUNDS. | |
| ES2099522T3 (en) | PROCEDURE FOR DYING ORGANIC MEDIA. | |
| MX9304399A (en) | NOVEL PROCESS TO PREPARE [[2-BROMOETHYL) -AMINO] METHYL] -2-NITRO-1H-IMIDAZOL-1-ETHANOL CHIRAL AND RELATED COMPOUNDS. | |
| BR8108346A (en) | PROCESS FOR ENZYMATIC PREPARATION OF L-2-AMINO-4-METHYL-PHOSPHINOBUTYRIC ACID | |
| ES2190471T3 (en) | PROCEDURE TO PRODUCE GUANIDINE DERIVATIVES, INTERMEDIATES OF SUCH COMPOUNDS AND THEIR PRODUCTION. | |
| NO303635B1 (en) | Novel 2-substituted indan-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase | |
| PE34397A1 (en) | INHIBITION OF THE PHOTODESCOMPOSITION OF 2-OXYDOLES 3-SUBSTITUTED | |
| MX9301850A (en) | PROCEDURE FOR PRODUCING A SINGLE-STAY DYE | |
| ES2117132T3 (en) | DESFERRIOXAMINE-B SALTS AND THEIR USE AS EFFECTIVE IRON CHELELERS BY ORAL USE. | |
| ES2176463T3 (en) | PROCEDURE TO PRODUCE DERIVATIVES OF 1-HALO-3-AMINO-4FENIL-2-BUTANOL OPTICALLY ACTIVE. | |
| CO4890846A1 (en) | SUBSTITUTED PYRROLES | |
| ES2086442T3 (en) | DERIVATIVES OF FLUOROETILCAMPTOTECINA. | |
| ES2079797T3 (en) | ANTIBACTERIAL COMPOUND. | |
| ES2125309T3 (en) | DERIVATIVES OF THYOMARINOL AND PROCEDURES FOR ITS PREPARATION. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |